1261392-79-3
1261392-79-3
Chemical Structure
Deferasirox-13C6
Synonym(s): ICL 670-13C6
- CAS No.: 1261392-79-3
- Formula:C1513C6H15N3O4
- Molecular Weight:379.32
InChIKey: BOFQWVMAQOTZIW-CIXUPELNSA-N
SMILES: OC1=C(C=CC=C1)C2=NC(C3=C(C=CC=C3)O)=NN2[13C]4=[13CH][13CH]=[13C]([13CH]=[13CH]4)C(O)=O
Biological Activity: Deferasirox-13C6 (ICL 670-13C6) is 13C labeled Deferasirox. Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Deferasirox-13C6 | Deferasirox-13C6 (ICL 670-13C6) is 13C labeled Deferasirox. Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Deferasirox (Standard) | ≥98% | Deferasirox (Standard) is the analytical standard of Deferasirox. This product is intended for research and analytical applications. Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Deferasirox-d4 | Deferasirox-d4 is the deuterium labeled Deferasirox. Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Deferasirox | 99.86% | Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.90
HY-178722Deferasirox methyl ester -
Similarity Score 0.68
HY-155997Anti-inflammatory agent 56 -
Similarity Score 0.67
HY-W740685Deferasirox acyl-β-D-glucuronide -
Similarity Score 0.64
HY-143333Nrf2 activator-3 -
Similarity Score 0.59
HY-16564Deferasirox (Fe3+ chelate) -
Similarity Score 0.55
HY-180943Antiparasitic agent-39 -
Similarity Score 0.53
HY-174149HDAC6-IN-59 -
Similarity Score 0.53
HY-W5869694-(9H-Carbazol-9-yl)benzoic acid -
Explore the MedChemAI to find more analogs
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Sobbe A, et al. Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox. J Gastroenterol Hepatol. 2015 Mar;30(3):638-45. [Content Brief]
- [3]. Kim JL, et al. The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targetingcaspase. Acta Haematol. 2011;126(4):241-5. [Content Brief]
